Similar Search Results

Recognizing public goods in WTO dispute settlement : who participates? Who decides? The case of TRIPS and pharmaceutical patent protection

Shaffer, Gregory C. - In: International public goods and transfer of technology …, (pp. 884-908). 2005

Persistent link: https://www.econbiz.de/10003415336

Economic analysis of pharmaceutical patent regime in India : a study in light of pre and post TRIPS regime

Parikh, Hardik H. - In: Law and economics : market, non-market and network …, (pp. 143-165). 2019

Persistent link: https://www.econbiz.de/10011950586

Intellectual property rights and pharmaceutical development

Rovira Forns, Joan - In: The economics of new health technologies : incentives, …, (pp. 219-239). 2009

Persistent link: https://www.econbiz.de/10003916101

Is product patent protection necessary to spur innovation in developing countries? : R&D by Indian pharmaceutical companies after TRIPS

Chaudhuri, Sudip - In: The development agenda : global intellectual property …, (pp. 266-291). 2009

Persistent link: https://www.econbiz.de/10003910930

IPR and drugs and the pharmaceutical industry : concerns for developing countries

Raizada, B. K.; Sayed, Javed - In: Salvaging the WTO's future : Doha and beyond, (pp. 274-289). 2002

Persistent link: https://www.econbiz.de/10001703150

Is drug patent protection a determinant of the location of pharmaceutical FDI? : China's experience

Yacoub, Nejla; Souei, Hajer - In: Innovation, catch-up and sustainable development : a …, (pp. 209-230). 2021

The economic literature reveals that the relationship between patents and Foreign Direct Investments (FDI) depends on industries and countries’ features. Our research considers the pharmaceutical industry in China. This choice stems from a contradictory observation: China is known for its...

Persistent link: https://www.econbiz.de/10012794273